NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents

VRC致力于通过严格追求有效的人类疾病疫苗来改善全球人类健康。NIAID的任务和范围包括通过研究、开发和临床测试针对由威胁公共健康的病原体引起的疾病的疗法和疫苗，以及新出现和重新出现的传染病，如埃博拉、寨卡和疟疾，快速应对传染病爆发。

The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development and clinical testing of therapeutics and vaccines against diseases caused by pathogens that threaten public health such as, HIV, pandemic influenza, and emerging and re-emerging infectious diseases like Ebola, Zika, and Malaria.